Studies show there is a tendency for decreased clinical and serological lupus activity following the onset of end-stage renal disease. The pathophysiology of this quiescence remains unclear. Survival of lupus patients on dialysis is no different from that of non-SLE dialysis patients, and is better than several other rheumatic diseases. Following renal transplantation, there is no difference in patient or graft survival in lupus versus non-lupus patients. Recurrence of lupus in transplanted allografts occurs at a rate (2.7 to 3.8%) comparable to that for all allograft transplant failures (2% to 4%).
A case of "maybe spoke too soon"? Scientist asks for potentially groundbreaking stem cell research to be withdrawn http://t.co/Crsek9Uvy2
Primecuts – This Week In The Journals http://t.co/r1G3CARo3L
A new blood test that could potentially aid in earlier diagnosis of Alzheimer's http://t.co/xKYQKI1973
To vanc or not to vanc? CDC study: Antibiotic misuse can put patients at risk http://t.co/TrbRhMxWBT via @washingtonpost
Behind the smoke curtain: Rising E-Cigarette Use Tied to More Smoking in Teens: MedlinePlus http://t.co/8EO13XlTKZ